HSBC Holdings’s NextCure NXTC Stock Holding History

HSBC Holdings’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,438	Closed	-$8.09K	–	3017
2025 Q2	$8.09K	Hold	1,438	–	–	﹤0.01%	2999
2025 Q1	$8.45K	Sell	1,438 -9	-0.6%	-$79	﹤0.01%	2990
2024 Q4	$13.7K	Hold	1,447	–	–	﹤0.01%	3063
2024 Q3	$23.7K	Hold	1,447	–	–	﹤0.01%	2942
2024 Q2	$28K	Hold	1,447	–	–	﹤0.01%	2858
2024 Q1	$38.7K	Hold	1,447	–	–	﹤0.01%	2957
2023 Q4	$20K	Hold	1,447	–	–	﹤0.01%	2682
2023 Q3	$22.4K	Hold	1,447	–	–	﹤0.01%	2668
2023 Q2	$31.3K	Hold	1,447	–	–	﹤0.01%	2505
2023 Q1	$25.7K	Hold	1,447	–	–	﹤0.01%	2594
2022 Q4	$24.1K	Sell	1,447 -74	-5%	-$1.7K	﹤0.01%	3007
2022 Q3	$51K	Sell	1,521 -12	-0.8%	-$612	﹤0.01%	2814
2022 Q2	$88K	Hold	1,533	–	–	﹤0.01%	3059
2022 Q1	$91K	Hold	1,533	–	–	﹤0.01%	3137
2021 Q4	$112K	Hold	1,533	–	–	﹤0.01%	3125
2021 Q3	$125K	Hold	1,533	–	–	﹤0.01%	2857
2021 Q2	$146K	Buy	1,533 +236	+18%	+$24.1K	﹤0.01%	2807
2021 Q1	$151K	Buy	+1,297	New	+$188K	﹤0.01%	2588

Other funds holding NXTC

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CPA

Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings's NXTC Position: Q3 2025 in Review

HSBC Holdings sold out of NextCure (NXTC) in Q3 2025, closing a stake of 1,438 shares — an estimated $8.09K sold.

HSBC Holdings first reported a position in NXTC in Q1 2021 and held it in 18 quarters. The position peaked at $151K in Q1 2021. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

HSBC Holdings reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
HSBC Holdings sold 1,438 NextCure shares in Q3 2025, an estimated $8.09K.
HSBC Holdings first reported a position in NextCure in Q1 2021 and held it in 18 quarters.
HSBC Holdings's NextCure position peaked at $151K in Q1 2021.
17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.